Affiliated Organizations

groupof4VBHRC “The Catalyst”
Our goal is to create stronger working partnerships between Virginia academic research universities, the biotechnology industry and health delivery systems that lead to greater collaboration, more movement of ideas & technology from academia to industry and health delivery systems. The goal is to create an environment that fosters relationships that makes Virginia a leader in collaboration, innovation, startups and job creation.

VaBio
The Virginia Biotechnology Association, formed in 1992, is the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth of Virginia. More than 200 member organizations have joined forces to make Virginia Bio an effective advocate for the biopharmaceutical and device industries before federal, state and local policy-makers. Virginia Bio is the official state affiliate of the Biotechnology Innovation Organization (BIO), in Washington, D.C.

Virginia Tech Center for Drug Discovery
The mission of the Virginia Tech Center for Drug Discovery (VTCDD) is to advance the growth and stature of drug discovery and delivery research at Virginia Tech. To assist VT faculty members initiate basic and applied drug discovery and delivery research. To foster a dynamic environment that promotes the recruitment of high quality faculty and students and to vigorously pursue continuing education and economic growth through outreach activities with industry and government agencies.

Fiske Drug Discovery Laboratory (UVa)
The Fiske Drug Discovery Laboratory is the home of the Lazo Lab (LazoLand) and the Sharlow Lab (Sharlowville).

Virginia Center for Translational and Regulatory Science
The Virginia Center for Translational and Regulatory Sciences (VCTRS) will seek to address the challenges to the health care funding and delivery models by:
Providing unique, cutting-edge educational offerings to enable scientists, physicians, medical technologists, engineers and medical trainees to be versed in the processes that enable emerging innovations to reach clinical testing and beyond
Facilitating the exchange of information and expertise between research and clinical thought-leadership and regulators in the hopes of supporting the Agency’s mission to nimbly regulate innovative new therapies
Leveraging the Center’s expertise directly in the immediate support for advancing innovative new products and ideas through regulatory strategy and entrepreneurship

Virginia Commonwealth University Department of Medicinal Chemistry
Medicinal chemistry is at the forefront of innovation, blending synthetic chemistry, molecular modeling, computational biology, structural genomics, and pharmacology to discover and design new drugs, and investigate their interaction at the molecular, cellular, and whole-animal level. Our department in the School of Pharmacy at Virginia Commonwealth University (VCU) is forging new ground by continuing the tradition of applying the latest strategies and concepts from broad disciplines of science.

Academic Drug Discovery Consortium
ADDC is a non-profit entity established in 2012 by 5 prominent academic drug discovery centers with the following objectives:.
Establish an interactive network of the growing number of academic drug discovery scientists and centers.
Exchange know how and expertise related to drug discovery programs, technologies, faculty engagement, industry partnerships, contractual arrangements.
Create a central repository of drug discovery centers, partnerships, job opportunities, and events.
Provide education material related to the drug discovery process and the creation of an academic drug discovery center.
Provide a platform for partnering and collaboration between consortium members and the life science industry including pharma, biotech, CRO’s and other service providers.
Advocate/Advise to NIH and other funding agencies.
Establish meeting and programs specific to academic drug discovery.